Funds and ETFs Balchem Corporation

Equities

BCPC

US0576652004

Specialty Chemicals

Real-time Estimate Cboe BZX 02:49:49 2024-06-17 pm EDT 5-day change 1st Jan Change
153 USD +1.56% Intraday chart for Balchem Corporation +1.25% +2.80%

ETFs positioned on Balchem Corporation

Name Weight AuM 1st Jan change Investor Rating
0.00% 753 M€ +2.19% -
0.00% 2 M€ +3.16% -
0.00% 11 M€ +1.95% -
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
150.7 USD
Average target price
166 USD
Spread / Average Target
+10.16%
Consensus
  1. Stock Market
  2. Equities
  3. BCPC Stock
  4. Funds and ETFs Balchem Corporation